Építés alatt – nem éles oldal
Belépés
VisszavonvaFázis nélkül

Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA

A legfontosabb adatok

Ki végzi
Yale University
Hol
New Haven (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Visszavonva
Kezdés
2025. dec.
Várható befejezés
2030. jún.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • Blood draw to measure the levels of dd-cf DNA
A regiszteradat frissítve
2025. november 6.
Miért állt le
Protocol was not approved by the sponsor; therefore PI not moving forward with this study.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 12 feltétel megnézéseKevesebb

Ki nem vehet részt

  • Multiorgan transplantation
  • Less than 3 years from transplantation
  • Life expectancy <1 year due to non-cardiac conditions
  • Patient appears unlikely or unable to participate in the required study procedures, as assessed by the study PI, study coordinator, or designee (ex: clinically-significant psychiatric, addictive, or neurological disease)
  • Evidence of moderate to large area of ischemia on the PET

Egyéb feltételek

  • Potential subjects must meet all of the following criteria to be eligible for inclusion in the study:
  • General Inclusion Criteria:
  • The patient is over 18 years of age
  • The patient underwent orthotopic heart transplantation and is undergoing routine cardiac allograft vasculopathy (CAV) surveillance with PET
  • The patient has no evidence of cardiogenic shock
  • The patient has no evidence of acute rejection
  • The patient, or legally authorized representative, has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent, approved by the appropriate Institutional Review Board (IRB) or Ethics Committee (EC); Potential subjects will be excluded if any of the following conditions apply:

Helyszínek itt: Egyesült Államok

  • Yale New Haven HealthNew Haven, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of this research study is to understand if a blood test in people who have had heart transplants can detect and predict the following:

A teljes eredeti leírásKevesebb

* Blockages in the small blood vessels of the heart. * Whether small blockages can turn into more severe blockages in the future.

Participants will undergo blood draws once every 3 months in the first year of the study (4 blood draws total, taking 15 minutes each) and their medical records will be reviewed for 3 years after the date they are enrolled in the study.

A vizsgálat 2 csoportja

  • Low MFR (less than or equal to 1.5)

    Subjects who are found to have a low MFR of less than or equal to 1.5.

    Kezelés: Blood draw to measure the levels of dd-cf DNA

  • Normal MFR (greater than 1.5)

    Subjects who are found to have normal MFR of greater than 1.5.

    Kezelés: Blood draw to measure the levels of dd-cf DNA

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
The DEPICT Prospective Study: Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury as Assessed by Donor Derived Cell Free DNA Post Transplantation
A regiszteradat frissítve
2025. november 6.